Heidelberg Pharma AG
XBER:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XBER:HPHA
|
DE |
|
Wolfspeed Inc
NYSE:WOLF
|
US |
|
T
|
Treasury Wine Estates Ltd
F:T7W
|
AU |
|
One Stop Systems Inc
NASDAQ:OSS
|
US |
|
S
|
Sands China Ltd
XBER:599A
|
MO |
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
AU |
|
G
|
Gaussin SA
XMUN:1KK1
|
FR |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.26 EUR with a low forecast of 5.21 EUR and a high forecast of 5.41 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.26
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.26 EUR with a low forecast of 5.21 EUR and a high forecast of 5.41 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
